Hanspeter Rottensteiner

6 Patents

• US120916752024

  Gene Therapy of Hemophilia a Using Viral Vectors Encoding Recombinant FVIII Variants with Increased Expression

  Takeda Pharmaceutical Company Limited

  0 cites
• US119997982024

  Anti-factor IX Padua Antibodies

  TAKEDA PHARMACEUTICAL COMPANY LIMITED

  0 cites
• US117796352023

  Subcutaneous Administration of ADAMTS13

  TAKEDA PHARMACEUTICAL COMPANY LIMITED

  0 cites
• US117075362023

  Viral Vectors Encoding Recombinant FVIII Variants with Increased Expression for Gene Therapy of Hemophilia A

  Takeda Pharmaceutical Company Limited

  0 cites
• US115966712023

  Gene Therapy of Hemophilia B Using Viral Vectors Encoding Recombinant Fix Variants with Increased Expression

  Takeda Pharmaceutical Company Limited

  0 cites
• US115649922023

  Nucleophilic Catalysts for Oxime Linkage

  Takeda Pharmaceutical Company Limited

  0 cites